Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A0YZ
|
|||
Former ID |
DNC002409
|
|||
Drug Name |
PYZD-4409
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H7ClFN3O5
|
|||
Canonical SMILES |
C1=CC(=C(C=C1N2C(=O)C(=CC3=CC=C(O3)[N+](=O)[O-])C(=O)N2)Cl)F
|
|||
InChI |
1S/C14H7ClFN3O5/c15-10-5-7(1-3-11(10)16)18-14(21)9(13(20)17-18)6-8-2-4-12(24-8)19(22)23/h1-6H,(H,17,20)/b9-6-
|
|||
InChIKey |
MSYMKEYWUWVZQY-TWGQIWQCSA-N
|
|||
CAS Number |
CAS 423148-78-1
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Ubiquitin-activating enzyme E1 (UBAE1) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma. Blood. 2010 Mar 18;115(11):2251-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.